Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 144 de 371.

Grafa

Gilead Sciences gains EU approval for Trodelvy in first-line metastatic TNBC

Gilead Sciences (NASDAQ:GILD) announced that the European Commission has granted marketing authorization for Trodelvy (sacituzumab govitecan-hziy) as monotherapy for adult patients with unresectable or metastatic triple-negative breast cancer who have not received prior systemic therapy and are not candidates for PD-1 or PD-L1 inhibitor treatment.

Leia mais: Gilead Sciences gains EU approval for Trodelvy in first-line metastatic TNBC
Grafa

AbbVie receives European Commission approval for MAVIRET in acute hepatitis C

AbbVie (NYSE:ABBV) said the European Commission has granted approval for its oral antiviral MAVIRET (glecaprevir/pibrentasvir) to treat acute hepatitis C virus (HCV) infection in adults and pediatric patients aged 3 years and older with compensated liver disease, with or without cirrhosis.

Leia mais: AbbVie receives European Commission approval for MAVIRET in acute hepatitis C